Similarly to GnRH-I derivatives, GnRH-III (<EHWSHDWKPG–NH2) based peptide carriers have been also used in our laboratories to deliver anticancer agents like Dau selectively to GnRH-R expressing cancer cells [28,29,30,31]. The gene discussed is GNRHR; the disease is cancer.